{"doi":"10.1016/j.ejca.2017.11.011","title":"Analysis of NRAS gain in 657 patients with melanoma and evaluation of its sensitivity to a MEK inhibitor","abstract":null,"journal":"European Journal of Cancer","year":2018,"id":34605,"datarank":1.0746665559107975,"base_score":3.332204510175204,"endowment":3.332204510175204,"self_citation_contribution":0.49983067652628066,"citation_network_contribution":0.5748358793845167,"self_endowment_contribution":0.49983067652628066,"citer_contribution":0.5748358793845167,"corpus_percentile":null,"corpus_rank":null,"citation_count":27,"citer_count":19,"citers_with_citation_signal":16,"citers_with_endowment":16,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":178948,"name":"Xiaowen Wu","orcid":null,"position":1,"is_corresponding":false},{"id":178949,"name":"Jiayi Yu","orcid":null,"position":2,"is_corresponding":false},{"id":158021,"name":"Huan Yu","orcid":null,"position":3,"is_corresponding":false},{"id":178950,"name":"Tianxiao Xu","orcid":null,"position":4,"is_corresponding":false},{"id":33126,"name":"Kevin M. Brown","orcid":"0000-0002-8558-6711","position":5,"is_corresponding":false},{"id":62239,"name":"Xue Bai","orcid":"0000-0001-5725-2442","position":6,"is_corresponding":false},{"id":178951,"name":"Jie Dai","orcid":null,"position":7,"is_corresponding":false},{"id":178952,"name":"Meng Ma","orcid":null,"position":8,"is_corresponding":false},{"id":178953,"name":"Huan Tang","orcid":null,"position":9,"is_corresponding":false},{"id":178954,"name":"Lu Si","orcid":null,"position":10,"is_corresponding":false},{"id":178955,"name":"Zhihong Chi","orcid":null,"position":11,"is_corresponding":false},{"id":178956,"name":"Xinan Sheng","orcid":null,"position":12,"is_corresponding":false},{"id":178957,"name":"Chuanliang Cui","orcid":null,"position":13,"is_corresponding":false},{"id":178958,"name":"Yan Kong","orcid":"0000-0002-6368-2112","position":14,"is_corresponding":false},{"id":159409,"name":"Jun Guo","orcid":null,"position":15,"is_corresponding":false},{"id":178947,"name":"Junya Yan","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":3.332204510175204,"endowment":3.332204510175204,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"29245078","pmcid":null,"openalex_id":"https://openalex.org/W2771669056","authors":[],"funders":[{"funder_name":"National Natural Science Foundation of China","grant_id":"81672696","title":null},{"funder_name":"National Natural Science Foundation of China","grant_id":"81772912","title":null},{"funder_name":"Beijing Municipal Natural Science Foundation","grant_id":"7152033","title":null},{"funder_name":"Beijing Municipal Science and Technology Commission","grant_id":"Z151100003915074","title":null}],"total_grants":4,"fwci":1.2337,"citation_percentile":0.79596575,"influential_citations":0,"citation_trend":[{"year":2018,"count":3},{"year":2019,"count":4},{"year":2020,"count":4},{"year":2021,"count":5},{"year":2022,"count":2},{"year":2023,"count":2},{"year":2024,"count":3},{"year":2025,"count":1},{"year":2026,"count":3}],"oa_status":"closed","license":"https://www.elsevier.com/tdm/userlicense/1.0/","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S0959804917314089?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0959804917314089?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.ejca.2017.11.011","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/29245078","host_type":"repository"}],"fields_of_study":["Melanoma and MAPK Pathways","Neuroblastoma Research and Treatments","Cutaneous Melanoma Detection and Management","Medicine","Biology"],"mesh_terms":["Adult","Aged","Animals","Female","Humans","Male","Melanoma","Membrane Proteins","Middle Aged","Mutation","Gene Dosage","GTP Phosphohydrolases","Mitogen-Activated Protein Kinase Kinases","Cell Line, Tumor","Mice"],"keywords":["Neuroblastoma RAS viral oncogene homolog","Melanoma","Medicine","Cancer research","MAPK/ERK pathway","MEK inhibitor","Oncology","Internal medicine","Kinase","Cancer","Biology","Genetics","Prognosis","Targeted Therapy","Nras Gain"],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-09T19:14:33.637679Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}